These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity. Uri JV. Acta Microbiol Hung; 1987 Apr; 34(1):39-44. PubMed ID: 3630630 [Abstract] [Full Text] [Related]
28. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime. Harper PB. Clin Ther; 1984 Apr; 6(3):310-24. PubMed ID: 6609771 [Abstract] [Full Text] [Related]
33. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing. Fuchs PC, Barry AL, Thornsberry C, Jones RN, Gavan TL, Gerlach EH, Sommers HM. Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750 [Abstract] [Full Text] [Related]
34. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci. Menzies RE, Cornere BM, MacCulloch D. Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002 [Abstract] [Full Text] [Related]
35. Paradoxical susceptibility to cephalothin and cefamandole of a Klebsiella pneumoniae isolate producing extended-spectrum beta-lactamase (TEM-3). Gaillot O, Mallea M, Philippon A, Pages JM, Simonet M. J Antimicrob Chemother; 1996 Jan; 37(1):194-6. PubMed ID: 8647766 [No Abstract] [Full Text] [Related]